Your browser doesn't support javascript.
loading
Self-medication against COVID-19 in health workers in Conakry, Guinea
Abdoulaye, Toure; Saidouba Cherif, Camara; Alioune, Camara; Mamoudou, Conde; Delamou, Alexandre; Ibrahima, Camara; Salifou Talassone, Bangoura; Camara, Alimou; Mamadou Bobo, Diallo; Mamadou Bhoye, Keita; Kaba, Kourouma; Camara, Robert; Etard, Jean-François; Keita, Alpha-Kabinet.
  • Abdoulaye, Toure; n Infectiologie de Guinée (CERFIG),Université Gamal Abdel Nasser. Institut National de Santé Publique, Ministere de la Santé. Conakry. GN
  • Saidouba Cherif, Camara; Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Université Gamal Abdel Nasser. Conakry. GN
  • Alioune, Camara; Chaire de Santé Publique, Université Gamal Abdel Nasser de Conakry. Programme National de Lutte contre le Paludisme, Ministere de la Santé. Conakry. GN
  • Mamoudou, Conde; Institut National de Santé Publique, Ministere de la Santé. Conakry. GN
  • Delamou, Alexandre; Chaire de Santé Publique, Université Gamal Abdel Nasser de Conakry. Centre d'Excellence Africain de Prévention et de Contrôle des Maladies Transmissibles, Université Gamal Abdel Nasser. Conakry. GN
  • Ibrahima, Camara; Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Université Gamal Abdel Nasser. Conakry. GN
  • Salifou Talassone, Bangoura; Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Université Gamal Abdel Nasser. Conakry. GN
  • Camara, Alimou; Institut National de Santé Publique, Ministere de la Santé. Conakry. GN
  • Mamadou Bobo, Diallo; Institut National de Santé Publique, Ministere de la Santé. Conakry. GN
  • Mamadou Bhoye, Keita; Institut National de Santé Publique, Ministere de la Santé. Conakry. GN
  • Kaba, Kourouma; Institut National de Santé Publique, Ministere de la Santé. Conakry. GN
  • Camara, Robert; Institut National de Santé Publique, Ministere de la Santé. Conakry. GN
  • Etard, Jean-François; TransVIHMI, Institut de Recherche pour le Développement, Université de Montpellier, INSERM. Montpellier. FR
  • Keita, Alpha-Kabinet; Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Université Gamal Abdel Nasser. Institut National de Santé Publique, Ministere de la Santé. TransVIHMI, Institut de Recherche pour le Développement, Université de Montpellier, INSERM. Conakry. GN
J. Public Health Africa (Online) ; 13(2): 1-4, 2022. tables
Article in English | AIM | ID: biblio-1395577
ABSTRACT
Data regarding the prevalence and consequences of self-medication during the COVID-19 pandemic in Africa are very limited. The study aimed to explore the frequency and risk factors of self-medication against COVID-19 by health personnel in this study. This cross-sectional study took place in June 2021, in Conakry, in the all three national hospitals and the six community medical centers, and five primary health centers. A multivariate logistic regression model was performed to identify factors associated with self-medication. A total of 975 health workers with a median age of 31 (IQR 27-40) years, with 504 (51.7%) women were included. The majority were clinicians physicians (33.1%) or nurses (33.1%). Of all, 46.2% reported having had at least one COVID-19 symptom during the 12 months preceding the survey. The proportion of self-medication was 15.3% among national hospital staff, 12.20% in municipality medical centers and 22.6% in primary health centers (p=0.06). More than two-thirds (68.7%) who selfmedicated did not have a test for SARSCoV- 2 infection. They took antibiotics including azithromycin, amoxicillin, ampicillin (42.2%), acetaminophen (37.4%), vitamin C (27.9%), hydroxychloroquine (23.8%) and medicinal plants (13.6%). The median duration of self-medication was 4 days. Fatigue or asthenia, sore throat, loss of smell and sore throat of a close person were independently associated with selfmedication. Health care workers largely practiced self-medication during the Covid pandemic and without diagnostic testing. The results suggest the need for training and sensitization of medical personnel to avoid the consequences of the molecules used, including hepatotoxicity and antibiotic resistance
Subject(s)


Full text: Available Index: AIM (Africa) Main subject: COVID-19 Serological Testing / COVID-19 Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: J. Public Health Africa (Online) Year: 2022 Type: Article Institution/Affiliation country: Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Université Gamal Abdel Nasser/GN / Chaire de Santé Publique, Université Gamal Abdel Nasser de Conakry/GN / Institut National de Santé Publique, Ministere de la Santé/GN / TransVIHMI, Institut de Recherche pour le Développement, Université de Montpellier, INSERM/FR / n Infectiologie de Guinée (CERFIG),Université Gamal Abdel Nasser/GN

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: AIM (Africa) Main subject: COVID-19 Serological Testing / COVID-19 Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: J. Public Health Africa (Online) Year: 2022 Type: Article Institution/Affiliation country: Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Université Gamal Abdel Nasser/GN / Chaire de Santé Publique, Université Gamal Abdel Nasser de Conakry/GN / Institut National de Santé Publique, Ministere de la Santé/GN / TransVIHMI, Institut de Recherche pour le Développement, Université de Montpellier, INSERM/FR / n Infectiologie de Guinée (CERFIG),Université Gamal Abdel Nasser/GN